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ABSTRACT
Using a dansyl fluorescent probe attached to porcine 
Apolipoprotein A-I, experiments are conducted where isolated 
pig liver endoplasmic reticulum membrane lipids are added to 
the labeled protein. From fluorescence polarization and inten­
sity change measurements, qualitative evidence of the inter­
action between the protein and lioid is obtained. From 
Perrin Plots, the particle t-Lze is seen, to increase as lipid 
iB added to labeled protein. Also, changes in and
fluorescence quenching signify that the environment of the 
probe changes as lipid ie added to protein, again indicating 
interaction.
1 • INTRODUCTION
Serum lipoproteins, complexes of protein and lipid, 
function in the transport of water-insoluble lipids via the 
bloodstream to various organs throughout the body. Lipopro­
teins are physic lly distinguished by relative floatation rotes 
in high gravitational fields such as those found in the 
ultracentrifuge. They ore generally divided into four classes, 
namely chylomicrons, very low density, low density, and high 
density lipoproteins.
Chylomicrons oni very lov density lipoproteins (VLDL) 
are both transporters of triglycerides. Chylomicrons originate 
in the intestine wnile VLDL come from the liver. In the blood­
stream both undergo a partial delipidation whereby lipoprotein 
lipase hydrolyses the triglycerida to glycerol and free fatty 
acids* In the case of chylomicrons, th remaining remnant 
particles are degraded by the liver. However, when the tri­
glyceride is removed from VLDL, the result is a liporrotein 
particle with a higher density an 1 a cholesterol ester core; 
this is the low density lipoprotein.
The role of low density lipoproteins (LDL) has been 
fairly wel1 established. It is thought that LDLs transport 
cholesterol via the bloodstream to the peripheral cells.
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2Goldstein and Brown (1) have proposed a mechanism by which 
the cells internalize and metabolite the LDL. briefly, it 
involves the LDL binding to a high affinity receptor site on 
the cell’s exterior, followed by internalization of the com­
plex, protein degradation, and LDL cholesterol ester hydrolisia 
to free cholesterol and fatty acid. This process serves to 
inhibit the synthesis of endogenous cholesterol by inhibiting 
an enzyme involved in cholesterol biosynthesis.
The role of high density lipoproteins (HDL) is less clear, 
HDLs have generated interest because there is a negative correl­
ation between HDL levels and the incidence of cardiovascular 
disease (2). In other words, persons with higher levels of 
HDL are less prone to b afflicted with cardiovascular ise-ses 
such as atherosclerosis, Glomset (?) postulated that DDLs 
remove cholesterol from peripheral cells and transport it to 
the liver for r-moval from the body. Another function of HDL 
may be to comp“titively inhibit the binding of LDL to cellular 
receptor sites, thus preventing the uptake of the LDLs and 
the cholesterol contained within them (4-6),
The origin o i  HDL is not clear, either. Mature HDL 
particles are spherical in shape with a diameter of about 
100". and are rich in cholesterol esters. They also contain 
triglycerides, free cholesterol, and phospholipids. The polar 
lipids are believed to a s s s o c i n t e  with apolipoproteins on the 
exterior o f  the particles while the neutral lipids compose 
the core (7), he major apolipoprotein is Apo-A-I,
3It 13 believed that HDLs originate In the Ivor and 
Intestine as precursor apolipoproteln-lipid complexes (nascent 
HDL) which are quite different both in structure and composi­
tion from the mature particles found in the plasma. In rat 
Liver perfusion experiments, the perfusate was found to contain 
particles in the HDL density rant>:e. These nascent HDL par­
ticles were found to contain high levels of the protein Apo E 
and phospholipids but low levels of Apo A-I and cholesterol 
esters (8,9). In similar experiments where lecithin-cholesterol 
acyltransferase (LCAT) activity was inhibited, discoidal
o c
particles, kb a thick and 190 A in diameter, were found in the 
H^L density rung* (10). In humans, liver pertuslon experi­
ments were not performed, but similar rarticles were discovered 
in blood serum in certain cases. In patients with abnormal 
LCAT activity, such as those with familial LCAT deficiency
(11) or alcoholic hepatitis (12), discoidal HDL were found.
In the alcoholic hepatitis cane, the composition of the 
discoidal HDL wa found to be similar to nascent rat HP! (13).
As the patient's liver condition improved and LCAT activity 
was restored, the plasma HDL returned to normal composition
(12) . In view of this evidence, one c n conclude that dis­
coidal HP1 particles are secreted by the liver in t e absence 
of LCAT activity, furthermore, it can be deduced that LCAT 
activity is required to obtain the normal HDL structure and 
composition. Indeed, Glomset ()k) proposed some time ago 
that LCAT activity transforms discoidal HDL into spherical 
particles rich in choLesterol ester* The experimental data
4seem to confirm this postulate; when LCAT was added to plasma 
from patientn with abnormal LCAT activities, the discoidai 
HDL were transformed to spherical ones (15)#
The intestine is also suggested as a source oi nascent 
HDL, There is no direct evidence of the secretion of discoidal 
partici.es, but it is known that the intestine is a major source 
of Apo A-I in humans and rots (16,17)* It is known that the 
Apo A-I secreted by the intestine in chylomicrons and VLDL
appears rapidly in the HDL fraction (18).
still at the crux of tne matter is the manner by which 
protein and lipid associate to form the nascent HDL particles. 
HDL-density particles have been shown to exist in the Golgi 
apparatus of rat liver, and it has been suggested that the site 
of assembly may be in the smooth endoplasmic reticulum (19)♦
The mechanism of protein-lipid complex formation, however, is 
unknown. It is not known whether the reaction is catalyzed 
by a lipid transfer factor or whether it is spontaneous.
Jonas and Krajnovich (20) have demonstrated that human 
and bovine Apo A-I will spontaneously form complexes with pure ^  
synthetic phospholipids under certain conditions. Knowing 
this, it would be interesting then to determ'ne whether the 
came could be done with dispersions of liver endoplasmic 
reticulum (HR) membrane phospholipids.
The n i g  is a suitable animal to conduct such experiments 
on, for its lipoprotein rattem is similar to that of the 
human (21). Also, the structure and composition of its HDL 
are well known (22-24). Hsing fluorescent probes attached to
the Apo -I protein in fluorescence polarisation nnci inten­
sity experimentsf the spontaneous interaction between Apo A- 
and Liver W  phospholipids will be studied and discussed in 
view of our current knowledge.
IT. EXPERIMENTAL
A. ” AT TRIALS
Fresh pig blood and liver came from the University of 
Illinois Meat Science Laboratory9 Urbina, Illinois. Human 
Apolipoproteins A-I and C-I and complexes of human Apo A-I, 
dirayristoyl phophatidylcholine, and (1^ C) cholesterol were 
obtained from Dr. A .  Jonas. Adenosine monophosphate (5*), 
cytochrome c, bovine serum albumin, and dmsyi chloride were 
obtained from Sigma Chemical Co., St. Louis, Missouri.
Dialysis tubing was supplied by Spectrum Medical Instruments 
of Los Angeles, California, and Union Carbide Corp. of 
Chicago, Illinois. Eastman Silica Gel Chromatogram Sheets, 
without fluorescent indicator, were obtained from Lastmin 
T'odak Co., Rochester, New York, Class-backed Silica Cel 
60F-^54 thin layer chromatography sheets were purchased from 
^rinkmann Instruments, Dei Plaines, Illinois, Sephacryl 3-200 
gel filtration resin came from Pharmacia Fine Chemicals of 
Piscataway, New Jersey. Dowex 2X-8 anion exchange resin and 
Hiogel A-5M gel filtration resin were obtained from Bio-Pad 
Laboratories, Richmond, California.
B. INSTRUMENTS
High-speed centrifugation was carried out in a Beckman
6
7L5-b5 ultracentrifuge, while p Beckmar. preparative
centrifuge was used for low-speed spins. Absorbance readings 
were taken using a Beckman Model 35 Spectrophotometer; a 
Perkin-Elmer MPF-3 Fluorescence Spectrophotometer was used 
to obtain fluorescence intensity measurements. Fluorescence 
polarization values were measured on an SLM Instruments Series 
400 polarization spectrophotometer with Cornin: Glass 3-74 
emission filters and with the temperature controlled with a 
Forma Scientific MasterLine water bath. Radioactive 
scintillation counting was done on a Beckman LC-100C Liquid 
cintillation Counter. Lipid vesicles were prepared by the 
sonication of a lipid suspension with a Model 'N185 Sonifier 
produced by Heat lystems-TUtratronics, Inc. A Gilson Micro- 
fr»cti nator was used t collect fractions eluting from gel 
filtration columns. Rotovaror flash evaporator was used to 
remove organic solvent from extracted lipid samples, 
iyophilization fan carried out using a Virtis Model 10-117 
lyophi Lizer.
C. METHODS
1. Phosphorus Determination
Assays for organic phosphorus and inorganic phosphate 
were performed by the method of Chen al, (25). Various 
dilutions of an inorganic phosphate stock solution were used 
to construct a standard curve.
2. Protein Determination
8Protein concentration was determined by the method of 
Lowry et al (2b) aa modified by Markwell e_t a_l (27)• Solu­
tions of bovine serum albumin were used as standards to 
generate a standard curve.
3. Apo A-I Isolation
a. Isolation of Lipoproteins
The procedure used for lipoprotein separation wa3 based 
on that used for the bovine system by donas (28). KDTA was 
added to fresh pig biood at a concentration of 1 mg/ml to 
prevent coagulation, After refrigeration for a few hours, it 
was centrifuged at 30u0 rpm for 17 minutes using the JA-14 
rotor in the Beckman J-21B centrifuge, and the supernatant 
serum was removed by aspiration.
Lipoproteins were isolated from pig serum by differential 
centrifugation. Serum was centrifuged at 50,000 rpm at 15°C 
for 19 hours using a Ti 75.2 rotor in the Beckman L.5-65 
ultracentrifuge. This first spin floated chylomicrons and 
vLDLs which appeared as a white layer; they were removed by 
gentle suction. The remaining solution was adjisted to a 
density of 1.087 g/ml with solid Nad and centrifuged as 
before. The yellowish solution on top was removed and the 
solution left in the tubes was adjusted to a density of 
1.210 g/mi with solid NaBr and recentrifuged as described 
above. The white Layer which contained HDL was then removed. 
The H L and vLDL solutions were each dialyzed for 40 hours 
against five 1-Liter changes of 0.01^ EDTA at 5°C,
9b. Delipidation
The dialyzed HDL and VLDL solutions were delipidated.
The HDL solution was delipidated by two procedures to test the 
efficiency of each relative to the other.
1) Chloroform/Methanol Extraction 
This procedure is a modified version of the method of 
Veisgraber sst al (2y). The VLDL and about half of the HDL 
solution were lyophilized. •’ach was placed in a separate 
conical centrifuge tube, suspended in 10 ml coid chloroform: 
methanol (2:1 v/v), and allowed to sit at 5°C for oae hour. 
They were then centrifuged at 5*D00 rpm at 5°C for 5 minutes 
using the JA-20 rotor in the Beckman J-21D preparative cen- 
trifuge and whe supernatants decanted and discarded. The 
pellets wore suspended and recentrifuged as described above 
tnree times in 10 ml cold ethanol and one time in cold 
methanol. After the last centrifugation, a small amount of 
methanol was left in. The samples were stored at 5°C.
2) Ethanol/Ether Extraction
The other half of the HDL solution was delipidated with 
cold ethanol/ether following the procedure of Scanu (JO).
The extent of delipidation wan estimated by the amount 
of phospholipid phosphorus left after the extractions using 
the method of Chen et al (25)•
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c, Apolipoprotein Identification and Separation
In o .'der to verify the composition of the proteins ob­
tained from the delipidati>n of lipoporteins, sodium dodecyl- 
sulfate polyacrylamide gel electrophoresis was performed by 
the procedure of Weber and Osborn (30. Standards of human 
Apo A-l and Apo C-I were also run.
HDL apolipoproteins from both delipidation procedures 
were pooled and fractionated on Sephacryl >-200 in a buffer 
3jM in guanidine HC1, pH 8.2, 0.1M in Tris, and 0.00% in 
KDTA, using a 90 x 2,5 cm glass column kept at 5°C, Fractions 
of about k ml each were collected with a Gilson Micro fraction­
ator. Absorbances of the fractions were measured at 280 ns 
with a Beckman Model 35 Spectrophotometer. Pooled fractions 
containing Apo A-I were dialyzed against four 6-liter changes 
of 0.01^ KDTA at 5°C and finally lyophilized and stored below 
0°C until used,
k* Endoplasmic Reticulum Isolation
The procedure for isolating endoplasmic reticulum (ER) 
membranes from pig liver is based on the discontinuous 
sucrose gradient method for rat liver by Dallner (32). About 
30g of fresh pig liver were homogenized with 150 ml cold 
0.i»ifM sucrose in a kitchen blender. The homogenate was fil­
tered through three layers of cheesecloth to remove fibers 
and any large chunks of liver. The filtrate was centrifuged 
at 10,000 x £ at 5°C for 20 minutes to sediment heavier par­
ticles. The supernatants were pooled and adjusted to 150 ml
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with cold O. H M  sucrose. About 18 ml of the resulting 
suspension were placed In each of eight polycarbonate centri­
fuge tubes, A discontinuous sucrose gradient was created by 
layering 7 ml of 1.3M sucrose underneath the liver homogenate 
suspensions. The gradients were centrifuged in the Beckman 
LJ-65 ultracentrifuge at 105,000 x £ at 5°C for 7 hours. 
During the spin, the homogenate suspension separated into 
five fractions (Figure 1). These fractions were separated 
with a Pasteur pipet and stored in closed containers at 5°C. 
The white band in the middle of the gradient (Fraction 3) was 
believed to be smooth ER, The pellet at the bottom (Fraction 
5) was resuspended with a small amount of the liquid above it. 
Seven such batches were prepared and the respective fractions 
pooled.
5. Enzymatic Marker Assays
NADPH-cytochrome c reductase served as a marker for ER 
membranes, and 5' nucleotidase indicated plasma membrane con­
tamination. The NADPH-cytochrome c reductase assay was per­
formed by the method of Sottocasa e£ all, (33), Cytochrome 
reduction was monitored by following absorbance changes at 
550 nm using a molar extinction coefficient of 27.7 x 10 
cm^ mol” . The 5' nucleotidase assay was that used by 
Solyom and Trams (34). The inorganic phosphate released was 
determ'ned by the method of Chen at ai (25), Protein contents 
were determined by the method of Markwell ,et al (27) in order 
to compute specific activities.
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6. Folch Lipid Extraction
Total lipids were extracted from the smooth BR mombrj'ies 
(Fraction 3) by the method of Folch et, al (35). One volume of 
ER membrane suspension was added to 19 volumes of a 2 :1 (v/v) 
chloroform:methanoi solution with stirring. Four volumes of 
a 0,73^ NaCl solution were then added and stirred. The result­
ing mixture was poured into a large graduated cylinder and 
allowed to equilibrate for 2-3 hours at 5°C, The bottom phase 
below the interf cial fluff was removed with a vacuum aspira­
tor. The solvent was removed from this lipid-soivent solution 
by a Rotovapor flash evaporator.
7 , TLC Methods
Thin layer chromatography (TLC) of lipids was performed 
using two different systems. Nonpolar lipids were chromato- 
grammed on Kastman ’llica Gel Chromatogram Cheats using a 
mixture of petroleum ether : diethyl ether : acetic acid 
(90:10:1 v/v/v) as the solvent. Polar lipids were run on 
Prinkmann Instruments Silica Gel 60F-254 glass-backed plates 
using chloroform : methanol : acetic acid : water (70:30:10:3 
v/v/v/v) as a solvent. Appropriate lipid standards were also 
run. Spots were made visible by exposure of the plates to 
iodine vapors,
8, Nonpolar Lipid Extraction
Enrichment of the ER lipid sample in polar lipids was 
accomplished by the extraction of the neutral lipids with
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acetone. The nonpolar lipids dissolved in the acetone while 
the polar ones precipitated. The liquid was decanted, and the 
precipitate was dried, weighed, and dissolved in a small 
amount of chloroform:methanol (2:1 v/v). Phospholipid was 
assayed for in both the acetone extract and precipitate by 
the method of Chen et al (23).
9. Lipid Vesicle Preparation
Lipid vesicles were prepared for protein-lipid inter­
action experiments by suspending the dried polar lipid in 
a buffer containing:
0.01M Tris 
0.005% EDTA 
0.001M NaN,
0.10M NaCl pH 8.0
The suspension was sonicated for 310 minutes on the Heat Systems- 
iJltri sonic s ’.VI85 ''onifier at a power setting of under a 
nitrogen atmosphere in the dark. The sample was centrifuged 
at 30,000 rpm for 30 minutes at 5°C in the Ti 50 rotor using 
the Beckman L5-65 ultracentrifuge in order to remove any large 
lipid sheets and any metal particles from the sonicator tip.
The supernatant contained the lirid vesicles.
10. Dansyl Labeling of Ap© A-I
The Apo A-I protein was labeled with daneyl chloride 
(Dns-Cl) by the method of Weber (36) a6 modified by Jonas (37). 
The protein concentration of the resultant solution was
14
determined by the method of Markwell e_t al (27).
11. Fluorescence Polarization Measurements
Changes in Dns fluorescence upon the titration of
labeled Apo A-I with lipid vesicles were measured on the SLM 
Instruments polarization spectrophotometer using Corning 
Glass 3-74 emission filters. The excitation wavelength was 
set at 340 nm, and the temperature of the simple was main­
tained at 37.0°C with a Forma Scientific Maeterline water 
bath attached to the cuvette holder. Two ml of danaylated 
Apo A-I (Dns-Apo A-I protein content 0.11 mg/ml) were placed 
in a quartz fluorescence cuvette and allowed to equilibrate 
at 57°C; 0.4 ml of lipid vesicles containing 4.8 mg phospholi­
pid (PL) per ml wore added in 10-50 ml aliquots. After each 
addition of lipid, the mixture was stirred thouroghly and 
allowed to equilibrate at 37°0 for five minutes. Polarization 
measurements were then taken.
12. Perrin Plots
Data for Perrin Plots were obtained by measuring Dns 
fluorescence polarization while varying the viscosities of 
protein-lipid and free labeled protein solutions. A sample 
of 2,0 ml Dns-Apo A-I (0.11 mg Apo A-I/ml) plus 0.4 ml lipid 
vesicles (4.8 mg PL/ml) were equilibrated at 37°C to allow them 
to react. Also, a reference sample of 2.0 ml Dns-Apo A-I 
solution plus 0.4 ml Tris buffer (pg. 13) was prepared. Pre­
determined amounts of othanol-recrystallized sucrose
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corresponding to known viscosities were added and mixed. 
Fluorescence polarization measurements were taken at 25.0°C 
using the SLM polarization spectrophotometer with the temp­
erature held constant by a Forma Scientific water bath.
13. A x and Fluorescence Intensity Changes
Measurements of changes in wavelength of maximum
fluorescence intensity (x___) and changes in lntesnity atin six
(quenching) were performed on the Perkin-alraer MPF-5max
Fluorescence Spectrophotometer using an excitation wavelength 
of nm. Two ml of Dns-Apo A-J solution (0*n mg protein/ml) 
were placed in a fluorescence cuvette; a total of 0. ' ml of 
lipid vesicle suspension (*4.8 mg PL/ml) were added in 20 pi 
liquets to give a four-fold excess of phospholipid to protein, 
by weight# After each addition, the mixture was allowed to 
equilibrate for 5 minutes.at room temperature, and the 
fluorescence intensity spectrum from M >0 to 5k0 nm was taken* 
The wavelength of maximum fluorescence intensity was noted 
after each run*
1/4, Gel Filtration Giving of Complexes
Determination of protein-lipid c mplex size was accom­
plished by passing a reaction mixture of Dns-Apo '-I and lipid 
vesicles through a 3io Gel A-5M column (^5 x 1.8 cm)* The 
reaction mixture was prepared by mixing lipid vesicles and 
Dns-Apo A-1 solution in a r *tic of *+: 1, phospholipid:protein, 
by weight. It was incubated at 37°C for five hours to allow
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complex formation to occur. One ml of this mixture was 
loaded on the column and eluted with the same Tris buffer whose 
composition is given on page 13* except that 0.15M NaCl was 
used instead of 0.10M NaCl. Fractions of approximately 2 ml 
each worm collected using a Gilson Microfractionator. A 
sample of Dns-Apo '-I w s parsed through the column separately 
in the same manner. Fluorescence intensities were measured on 
the Perkin-Elmer MPF-5 Fluorescence Spectrophotometer at room 
temperature with excitation and emission wavelength settings 
of 340 and 500 nm, respectively. The elution peaks of the 
protein-lipid mixture and the free protein solution were com­
pared, The five fractions of the eluted protein-lipid mixture 
containing the most fluorescent label (Fractions 39-43) were 
pooled for the determination of the protein:phospholipid 
ratio. Phospholipid phosphorus was determined by the method 
of Chen et al_ (25). Protein concentration of porcine Apo A-I 
was determined by absorbance at 280 nm after accounting for 
Dns absorbance using Dns molar extinction coefficients of 
1.85 x 10 ' and 4.30 x 10  ^M',1cm"’ 1 at 280 and 340 nm, respec­
tively (36). The extinction coefficient used for porcine 
Apo A-I was taken to be the average of that of human and 
bovine Apo A-I, since no coefficient for porcino Apo A-I 
waa available; this averaged value was calculated to be 
12,0 x 102 g“1cm? (28,38). A molecular weight of 27,000 for 
porcine Apo A-I was assumed.
A reference complex of human Apo A-I, dimyristoyl 
phosphatidylcholine, and cholesterol of molecular weight
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around <f00,000 (59) was also sluted through the column; in 
this case the elution pattern was determined by measuring 
the <^c) cholesterol counts psr minute in the fractions.
This pattern was compared with that obtained from Dne-Apo A-I 
plus lipid and that of free Dns-Apo A-I.
III. RESULTS AND DISCUSSION
Two methods of lipoprotein delipidation were performed 
for comparison of completeness of lipid extraction. Both the 
Weisgraber (chloroform/methanol) and Scanu (ethanoi/ether) 
methods of delipidation left less than \% of phospholipid (PL) 
by weight in the apolipoprotein samples. The VLDL extracted 
by the Weisgraber procedure had approximately 0.75^ PL by 
weight, assuming an average PL molecular weight of 775. The 
HDL delipidated by the Scanu method had about O.H# PL by 
weight, while that treated by the Weisgraber procedure had 
essentially no phospholipid within the range of the phosphorus 
assay. It is difficult to determine whether the Weisgraber 
delipidation was more complete than the Scanu method based on 
the HDL extraction data, for small absolute errors here lead 
to large relative errors. In any case, both methods seem to 
remove most of the lipid, judging from the phospholipid 
contents.
The poLyacrylamide gel electrophoresis indicated that 
the delipidated HDL was rich in Apo A-I; dark bands in the 
gels containing delipidated HDL had migrated to a position 
similar to that of the human Apo A-I standard (Figure 2),
The human Apo C-I standard gel had no dark band, only a light 
one near the end. It is possible that the Apo C-I, being a
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relatively low molecular weight protein, ran off the end* The 
pig VLDL protein gel showed a very dark band near the end, but 
its identity was unknown. It wa6 concluded that Apo A-I was 
the major protein in the delipidated HDL protein samples, and 
that it could be isolated by gel filtration.
A graph of absorbance at 280 nm versus fraction number 
for the gel filtration of the HOL apolipoproteins is shown 
in Figure 3. The large peak represents Apo A-I} fractions 
53-64 were used in the Apo A-I isolation. (The smaller peak 
to the right represents Apo C.)
The isolation of F.R from liver homogenate by the discon­
tinuous sucrose gradient method produced five dlstinc frac­
tions (Figure 1). From the description of Dallner (29), 
Fraction 3, the white band near the former location of the 
0,44 - 1.3M sucrose interface, was assumed to be the smooth 
ER, and Fraction 5 the rough ER. To test this assumption, the 
activity of NADPH-cytochrome c reductase, an ER marker enzyme, 
was assayed. The reduction of cytochrome was monitored by 
absorbance at 550 nm. Protein concentrations were also 
determined, so specific and total activities could be calcu­
lated. These assays were performed on the fractions obtained 
by ultracentrifugation as well as on the pellet discarded 
after the initial low-speed centrifugation. The specific 
activity gives the activity per milligram of protein, and the 
total activity gives the total amount of activity present.
The data are presented in Table 1 . The highest specific 
activities were in Fractions 3, 4, and 5; thus confirming the
20
earlier assumptions* The low-speed centrifugation pellet 
gave the highest total activity by far, indicating that most 
of the SR membranes are there, but the lower specific activity 
suggests that there are more contaminants there than are in 
Fractions 3, if, and 5.
One possible source of contaminants in the SR fractions 
could be from cell plasma membranes; 3* nucleotidase is an 
enzymatic marker for plasma membranes. Its activity is 
measured by the amount of inorganic phosphate released when 
the enzyme cleaves off the phosphate group of 5 ' adenosine 
monophosphate in a given time. Again, the assays were per­
formed on the ultricentrifugation fractions (1-5) and the 
pellet discarded after the low-speed centrifugation, The data 
are presented in Table 2, The specific activities are 
relatively close for all fractions. However, the total ac­
tivity values reveal that the vast majority of the plasma 
membranes are in the pellet obtained from the low-speed cen­
trifugation. In fact, this pellet contained about 82% of all 
the 5* nucleotidase activity. From these enzymatic assays, it 
vas decided that the GR preparation was reasonably free from 
contaminating plasma membranes, and that the HR was pure 
enough for our purposes.
It was decided to use Fraction 3, the smooth GR, for our 
experiments. The total lipids were extracted with organic 
solvents. To test the composition of the isolated lipids, 
thin Layer chromatograms (TLCs) were run. A solvent system 
for nonpolar lipids was used in which the most neutral lipids
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migrate the farthest. Polar lipids, including phospholipids, 
tend tc remain at or near the origin. After the chromatogram 
was developed (Figure k)t it was found that there was a rela­
tively large amount of neutral lipid compared to polar lipid. 
Since it is the polar lipids, especially phospholipids, which 
interact with apolipoproteins to form nascent HDL, it was 
decided to extract the nonpolar lipids and thus enrich the 
lipid mixture with phospholipids. It is not certain where the 
neutral lipids originated. Perhaps the ER contained some 
triglyceride pools. Knowing that phosphatidylcholine, a 
phospholipid, is insoluble in acetone, it was assumed that 
most other phospholipids would also be, and that the trigly­
cerides could be removed by extracting them with this organic 
solvent. The precipitate obtained from this process was then 
assumed to contain the phospholipids. In fact, it was round 
to contain 60 mg of phospholipid in 100 mg total lipid, assum­
ing that the average phospholipid molecular weight is 775*
This "enriched" fraction thus contains about 60% phospholipid 
by weight. On the other hand, before extraction the total 
lipid mixture contained only 1 1"'> PL by weight (152 mg PL in 
1157 mg total lipid). Therefore, the acetone extraction did 
indeed enrich the PL concentration, but also caused a loss of 
some. However, the amount recovered was sufficient for our 
experiments. As a qualitative test, TLCs of the polar lipid 
precipitate and the nonpolar acetone extract were run against 
various lipid standards in both polar and nonpolar systems. 
Judging from the sizes and intensities of the spots, most of
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the neutral lipids were removed by the acetone wash (Figures 
5«6). On the nonpolar chromatogram, the acetone extract 
showed a dark spot that had migrated the same distanee as the 
triglyceride standard. The polar lipid precipitate showed 
little migration. On the polar chromatogram, the polar lipid 
precipitate showed a dark spot at the same distance from the 
origin as the phosphatidylcholine standard. There were also 
some other spots corresponding to other polar lipids. The 
acetone extract showed little movement except for a small 
phosphatidylcholine spot. Thus it appears that most of the 
lipids in the polar lipid precipitate are indeed polar.
The lipid was assumed to be of an appropriate composition 
to perform protein-lipid interaction studies with. Lipid 
vesicles were produced by sonicatlon. The interaction studies 
were then carried out using a fluorescent probe attached to 
Apo A-I, Changes in the protein structure during interaction 
with lipid were inferred from changes in fluorescence 
properties.
It would be appropriate here to mention a few words 
about fluorescence. Basically, an aromatic organic molecule 
can absorb a photon at a given wavelength, thus raising the 
molecule to an excited energy state. This excited molecule 
can later emit a photon and drop back to the ground state.
The time between these events is called the fluorescence 
lifetime, and the emission of the photon is called fluorescence. 
Because the excited molecule loses energy through molecular 
collisions and interactions before fluorescence occurs, the
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eBitted photon has less energy than the absorbed one, and thus 
the emitted wavelength is longer than that absorbed. The 
fluorescent probe used in our experiments was dansyl chloride 
(Dns-Cl). It was covalently attached to the Apo A-1 protein 
molecule (Dns-Apo A-I). Its excitation wavelength is near 
34O nm, whereas its emission wavelength is around 500nm. Its 
fluorescence lifetime is about 12 nanoseconds.
When plane polarized light is used to excite fluorescent 
molecules, measurement of fluorescence intensity at right 
angles to the incident light gives two components; intensities 
of light parallel and perpendicular to the plane of the inci­
dent light, denoted by I„ and IA , respectively. The polar­
ization "p" is defined as:
la + Ij.
In most cases, a change in polarization is indicative of a 
change Jn rotational relaxation time, which in turn signifies 
that the volume of the fluorescent particle has changed. How­
ever, a lack o<* polarisation change does not necessarily 
rule out interaction, because local rotational motions of the 
probe can possibly compensate for the slower rotational motion 
of the larger complex particle,
A useful method for quantitating the volume and rotation- 
al relaxation time of the fluorescent particle is the use of 
Perrin Plots, Here, polarization is measured as solution
viscosity or temperature is changed. In our experiments, 
solution viscosity was varied by the addition of sucrose. A 
plot of 1/p versus T/| is constructed, where p is fluorescence 
polarisation, T is the temperature, and 9 is the viscosity. 
When the curve is extrapolated to = 0, the intercept on 
the vertical axis is 1/p0 • the inverse of the limiting 
polarization. The Perrin equation (.kO) as modified by Weber 
( 1 ) can then be applied:
(1/p - 1/3) = d / p 0 - 1/5)0 ♦ v / h )
T* is the fluorescence lifetime, and fa is the rotational 
relaxation time. In the case of a spherical particle, f>h 
is given by the expression;
*
V is the particle volume, and K is the gas constant. This 
equation shows that the rotational relaxation time is pro­
portional to r rticle volume.
Another useful fluorescence method to examine protein- 
lipid interactions is the change of wavelength of peak 
fluorescence of the probe (Am.x)» *hen a labeled protein 
molecule is in contact with aqueous solvent, there is some 
interaction between the dipoles of the fluorescent probe and 
the surrounding water molecules. Some of the energy of the
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excited state is lost here* However, when the labeled
protein nolecule is associated with lipid, the dipole inter—
actions in the excited state are lessened* Therefore, not as
much energy is lost in thi6 case, and tho emitted photon ban
greater energy th m  in the situation where the molecule was
surrounded by water. Thus, the wavelength of emitted light
is shorter when the labeled protein is bound to lipid than
when it is not. This is called a blue shift. In addition to
x changes, intensity changes can also occur. This is max
indicative of a change in the environment of the probe. In 
most cases, fluorescence quenching effects (i.e. changes in 
intensity) in a protein molecule cannot be attributed to a 
single intramolecular or extramolecular interaction, but do 
reflect environment changes around the chromophore.
The data for polarization measurements taken as Dns-Apo a-I 
was titrated with lipid are presented in Figure 7. The 
polarization remained steady around 0 .19 3 and did not begin 
to rise until about 80 » 1 of lipid vesicles had been added.
The polarization had only risen to about 0.204 by the time 
1*00 **1 of lipid vesicles had been added, corresponding to a 
PLtproteln molar ratio of about 300:1. This shift in 
polarisation /alues is small and not significant when com­
pared to those obtained by Jonas and Krajnovich (20) for the 
titration of human Apo A-I with dimyristoyl phosphatidyl­
choline. They obtained a change of polarization value from 
0.18 to 0,23. In addition, their studies 3how an immediate 
increase in polarization upon the addition of lipid. The lack
2b
of a Large polarization increase in our experiments, however, 
does not rule out the occurrence of protein-lipid associations. 
The model for fluorescence studies for this typo of inter­
action assumes t at the fluorescent probe is rigidly bound to 
a spherical complex. However, the labeled protein is not 
tightly bound to the lipid, and the protein can rotate carry­
ing the probe with it. The rotation of the probe causes 
changes in the polarization. Also, the lack of a significant 
polarization increase could be a kinetic effect in which more 
time was needed to form complexes than was allowed in the 
experiment. Therefore, the data are inconclusive. The rise 
in polarization that did occur may be due to light scattering 
caused by turbidity induced by the relatively large amount of 
insoluble linid in the solution.
The construction of Perrin Plots gave better results, A 
solution of Dns-Apo A-I incubated with lipid vesicles and a 
solution of free Dns-Apo A-I were used. Both solutions had 
the same concentration of protein (0.092 mg Apo A-I/ml).
The lipid-protein mixture had an 8.7:1 weight excess of PL 
over protein, or a 300:1 molar excess, which should have been 
more than enough for complete complex formation (20), 
was varied by altering viscosity by the addition of sucrose. 
The data are presented in Figure 8. The rotational relax­
ation time ot pro twin-lipid mixture particles was
about 270 nanoseconds while that for the free Dns-Apo A-I 
was about 80 ns. Since ^  i8 proportional to particle volume, 
the volume of tne particles in the Hpid-protein mixture was
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greater than that of the protein alone. Therefore, the pro­
tein Bust have associated with the lipid vesicles in order 
to increase narticle size. The value obtained here for ro­
tational relaxation time agrees well with those obtained by 
Jonas and Krajnovich (20) for interaction between dimyristoyl 
phosphatidylcholine and hunan and bovine 4po A-I. Their 
complexes had average isothermal p. values of 250 + 50 and 
280 + 80 ns for human and bovine Apo A-I, respectively.
The data from the fluorescence A_ „ and intensitymax
change studies also indicated complex formation (Figures 9»10) 
Before the labeled protein was titrated with lipid, the A 
value was 501 nn with a peak intensity of 57%. The intensity 
was measured on a relative (%) scale. Upon titration with
lipid vesicles, the value ofA__ decreased. The rate of change
decreased as more lipid was added as it approached its limiting 
value. If we assume that the limiting value of A ___ is 
A95 nm and extrapolate the initial slope of the A g ^  
lipid added curve to this value, we obtain a "saturation" 
value of lipid of 70 pi, corresponding to a 55s1 molar PL: 
protein ratio. The saturation value is the amount of lipid 
required to react with all the protein in the comrlex- 
forming reaction. The ABax change itself indicates that the 
environment of the Dns probe has changed, but the change in 
A x intensity found reinforces this point. Upon titration 
with lipid, the intensity a t A nax rapidly rose to about 
69% and leveled off. If we again extrapolate the initial 
slope of the intensity vs. lipid added curve to this 69%
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Uniting value, we obtain a saturation value of about 4*0 jtl 
lipid or a 30:1 molar PLtproteln ratio. This value is not 
close to the ratio obtained fron the X change data, but
luolX
one must bear in nind that the extrapolation aethods are 
very rough and that all nuabers given are only estinates.
In addition, there is an uncertainty of ♦ 1 nm in the A 
values.
Additional information on coaplex formation can be 
obtained fron gel filtration column experiments. Basically, 
the system employed separates particles by size. The gel 
beads contain pores of a certain size in which small mole­
cules passing down the column will pass through. Large 
molecules, which are too big to fit in the pores, pass around 
the gel beads instead of through them. The particles passing 
through the pores are slowed down while going through them.
The result is that larger particles run the length of the 
column faster than small ones, and therefore elute first. In 
our studies, free Dns-Apo A-I and a mixture of Dns-Apo A-I and 
lipid vesicles were passed through the column separately. If 
the protein and lipid have indeed formed complexes, they 
should elute in a fraction ahead of where free protein comes 
off, since complexes are larger than single protein molecules. 
As it turned out, the distinction was not very great. As 
determined by fluorescence intensity measurements, the peak 
concentration of labeled protein, possibly bound to lipid, 
was in fraction 4*1, while that for free Dns-Apo A-I was in 
fraction 4*2 (Figures 11,12). This is not a significant
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shift, so the data Bust be interpreted as inconclusive.
The elution pattern of the hunan Apo A-I - dlmyristoyl 
phosphatidylcholine - ('^C) cholesterol conplexes (Figure 
13) of aolecular weight 200,000 suggests that the protein- 
lipid complexes produced here are of a similar molecular 
weight, assuming that complexes were ind ed formed. The
Hpeak concentration of the ( ^C)-containing complexes was in 
fraction 1»1, the same fraction number in which eluted the 
peak concentration of labeled protein in the Dns-Apo A-I/ 
iipld mixture, (The smaller peak to the left of the main 
peak in Figure 13 nay have been some contamination in the 
column.)
In light of the other experiments conducted, it appears 
as if porcine Apo A-I and ER lipids do indeed form complexes.
To resolve this discrepancy with the gel filtration experi­
ment, it should be noted that the free protein might exist in 
an oligomeric form. According to Jonas and Krajnovich (20), 
bovine Apo A-I occurs in such a form which evidently dissociates 
to monomeric units when Interacting with lipids. If this 
were the case with porcine Apo A-I, it may explain why the 
free protein elutad in a position similar to that of the 
supposed lipid-protein complexes. The oligomer would be 
larger than the single protein molecule and thus would elute 
before the position expected for a monomeric protein. If 
these assumptions are valid, it appears then that the protein 
oligomers have a size similar to that of protein-lipid com­
plexes, However, the Perrin Plots suggest that the
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lipoprotein particles are ouch larger than the free protein 
particles, but the gel filtration data suggest that they are 
of a similar size. Another possibility is that the gel 
filtration elution pattern may depend on the symmetry and 
shape of the particle. If the lipiprotein and free protein 
particles have different symmetries, they may give different 
elution patterns which could not be compared. Therefore, the 
gel filtration results may be misleading.
The molar PL:protein ratio for the peak fractions of the 
Dns-Apo A-I / lipid reaction mixture was calculated to be 
<*7:1 which was fairly close to the 30:1 value calculated 
from the fluorescence quenching data, but did not agree well 
with the 7<J:1 ratio obtained from X x shifts. When forming 
complexes of synthetic dimyristoyi phosphatidylcholine (DMPC) 
with human and bovine Apo A-I, Jonas et al (42) obtained 
molar ratios in the vicinity of 90:1, PL:protein. Our results 
do not agree with these, but one must bear in mind that our 
lipid vesicles were only 60% phospholipid, so our PL:protein 
ratios do not really reflect what the total lipid:protein 
ratio is. Also, Jonas (43) has shown that the molar PLtprotein 
ratio varies depending on the type of phospholipid used; the 
number of PL molecules per protein molecule decreases with 
increasing PL hydrocarbon chain length and with increasing 
unsaturation. It is possible that our ratios are lower than 
those obtained for DMPC because the ER phospholipids may 
have longer hydrocarbon chains or more unsaturated bonds 
than DMPC.
31
The results obtained in these studies are fairly good 
qualitative indications that porcine Apo A-I does fora 
lipiprotein complexes with liver ER lioids. One should bear 
in mind that the quantitative values presented here are only 
estimates and were computed using some very crude approxima­
tions. Further experimentation will be needed to further 
quantitate the process and determine the mechanism. Also, 
the possibility that Apo A-I may interact with whole ER 
membranes is worth investigating.
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Table 1
NADPH - Cytochrome c Reductase Activity
Fraction
1
2
3
4
5
Specific Activity
/nmoles cyt-c reducedX 
V m g ,  prot - min /
Total Activity
Amoles cyt-c reduced\ 
\ min /
1.30 x 10"2 
1.02 x 10”2 
2.34 x 10”1 
4.0? x 10”1 
2.66 x 10” ’
1.53 
12.1
39.8 
3 M
25.9
Low-epeed
centrifugation 
pel Let 1.6 rl x 10
1 400
kS
Table 2
5' Nucleotidane Activity
Fraction 15 Minute 
Specific Activity
15 Minute 
Total Activity
/  Eg ,P f  \
^ng prot -  15 Bin 1 ^ H ^ £ « l £ i a £ 4  1
1 5.09 x 10"5 0.1*5
2 5.66 x io-5 6.72
3 3.29 x 10"2 5.59
k 3.70 x 10~2 2.83
5 1.21 X 10“2 1 . 1 8
Low-8peed
centrifugation 3.00 x 10”?
pellet
LIST OF AB^ R.r'VI \TIONf>
DMPC
Dns
EDT- 
HR
HDL
LCAT
LDL
ns
PL
TLC
Vs w,
L-oc-dimyristoyl phosphatidylcholine 
Danny1
Ethylenediaminetetraacetic acid 
Erdoplasmic reticuiun 
High density lipoprotein 
Lecithin-cholest* roi acy1 transferase 
I»ow density lipoprotein 
Nanosecond 
Phospholipid
T,hin layer chromatogram (chromatography) 
Very*low density lipoprotein
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